Unfavorable effect of calcitriol and its low-calcemic analogs on metastasis of 4T1 mouse mammary gland cancer
Artur Anisiewicz , Agata Pawlik , Beata Filip-Psurska , Eliza Turlej , Stanisław Dzimira , Magdalena Milczarek , Katarzyna Gdesz , Diana Papiernik , Joanna Jarosz , Dagmara Kłopotowska , Andrzej Kutner , Andrzej Mazur , Joanna Wietrzyk
AbstractLow vitamin D status is considered as a risk factor for breast cancer and has prognostic significance. Furthermore, vitamin D deficiency increases after adjuvant cancer therapy, which alters bone metabolism increasing the risk of osteoporosis. It is now postulated that vitamin D supplementation in breast cancer treatment delays the recurrence of cancer thereby extending survival. We evaluated the impact of calcitriol and its low-calcemic analogs, PRI-2191 and PRI-2205, on the tumor growth, angiogenesis, and metastasis of 4T1 mouse mammary gland cancer. Gene expression analysis related to cancer invasion/metastasis, real-time PCR, ELISA, western blotting, and histochemical studies were performed. In vitro studies were conducted to compare the effects of calcitriol and its analogs on 4T1 and 67NR cell proliferation and expression of selected proteins. Calcitriol and its analogs increased lung metastasis without influencing the growth of primary tumor. The levels of plasma 17β-estradiol and transforming growth factor β (TGFβ) were found to be elevated after treatment. Moreover, the results showed that tumor blood perfusion improved and osteopontin (OPN) levels increased, whereas vascular endothelial growth factor (VEGF) and TGFβ levels decreased in tumors from treated mice. All the studied treatments resulted in increased collagen content in the tumor tissue in the early step of tumor progression, and calcitriol caused an increase in collagen content in lung tissue. In addition, in vitro proliferation of 4T1 tumor cells was not found to be affected by calcitriol or its analogs in contrast to non-metastatic 67NR cells. Calcitriol and its analogs enhanced the metastatic potential of 4T1 mouse mammary gland cancer by inducing the secretion of OPN probably via host cells. In addition, OPN tumor overexpression prevailed over the decreasing tumor TGFβ level and blood vessel normalization via tumor VEGF deprivation induced by calcitriol and its analogs. Moreover, the increased plasma TGFβ and 17β-estradiol levels contributed to the facilitation of metastatic process.
|Journal series||International Journal of Oncology, ISSN 1019-6439, (A 25 pkt)|
|Publication size in sheets||2|
|Keywords in English||metastasis, calcitriol analog, 4T1 mouse mammary gland cancer, osteopontin,TGFβ|
|Internal identifier||64608; PX-5a573106d5dee69915d1cf7c|
|License||Journal (articles only); published final; ; after publication|
|Score||= 25.0, 15-06-2020, ArticleFromJournal|
|Publication indicators||= 10; = 11; : 2018 = 0.928; : 2018 = 3.571 (2) - 2018=3.356 (5)|
* presented citation count is obtained through Internet information analysis and it is close to the number calculated by the Publish or Perish system.